financetom
Business
financetom
/
Business
/
Labcorp Q1 Adjusted Earnings, Revenue Increase; 2025 Earnings Outlook Updated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Labcorp Q1 Adjusted Earnings, Revenue Increase; 2025 Earnings Outlook Updated
May 25, 2025 8:41 PM

07:17 AM EDT, 04/29/2025 (MT Newswires) -- Labcorp ( LH ) reported Q1 adjusted earnings Tuesday of $3.84 per share, up from $3.68 a year earlier.

Analysts polled by FactSet expected $3.74.

Revenue for the quarter ended March 31 was $3.35 billion, up from $3.18 billion a year earlier.

Analysts surveyed by FactSet expected $3.40 billion.

For 2025, the medical testing services company now expects adjusted EPS of $15.70 to $16.40, compared with its previous guidance of $15.60 to $16.40. Revenue for the full year is still expected to grow 6.7% to 8%. Analysts polled by FactSet expect $16.05 on sales of $13.92 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen beats quarterly profit estimates on strong demand for rare disease drugs
Biogen beats quarterly profit estimates on strong demand for rare disease drugs
May 25, 2025
May 1 (Reuters) - Biogen beat first-quarter profit and revenue expectations on Thursday, as strong demand for its rare disease drugs helped offset declining sales of its multiple sclerosis drugs. The drugmaker has been counting on newer launches such as genetic disorder drug Skyclarys as demand falls for its once top-selling multiple sclerosis medicines in the face of stiff competition...
Eli Lilly beats Q1 profit estimates on strength of diabetes drug
Eli Lilly beats Q1 profit estimates on strength of diabetes drug
May 25, 2025
May 1 (Reuters) - Eli Lilly ( LLY ) on Thursday reported first-quarter profit above Wall Street estimates, helped by strong sales of its widely popular weight-loss and diabetes drugs Zepbound and Mounjaro. On an adjusted basis, the U.S. drugmaker earned $3.34 per share for the quarter, compared with analysts' estimates of $3.02 per share, according to LSEG data. (Reporting...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Quanta beats quarterly profit estimates, raises annual profit forecast
Quanta beats quarterly profit estimates, raises annual profit forecast
May 25, 2025
May 1 (Reuters) - Energy contractor Quanta Services ( PWR ) beat first-quarter profit estimates and raised its annual forecast on Thursday, aided by sustained strength in demand for its infrastructure services. The ongoing power grid modernization and electrification in the U.S. and construction of data centers due to the AI boom is helping infrastructure service providers. Quanta also stands...
Copyright 2023-2026 - www.financetom.com All Rights Reserved